Christopher D. Galloway's most recent trade in CervoMed Inc was a trade of 305,743 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 27, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CervoMed Inc | Christopher D. Galloway | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 305,743 | 305,743 | - | - | Stock Option (Right to Buy) | |
| CervoMed Inc | Christopher D. Galloway | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 81,537 | 81,537 | - | - | Stock Option (Right to Buy) | |
| CervoMed Inc | Christopher D. Galloway | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 27,180 | 27,180 | - | - | Stock Option (Right to Buy) | |
| CervoMed Inc | Christopher D. Galloway | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2020 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) |